Skip to main content
. 2009 Jan;156(1):105–115. doi: 10.1111/j.1476-5381.2008.00012.x

Figure 4.

Figure 4

Chemoattractant-activated fura-2 fluorescence responses of control and montelukast (2 µmol·L−1)-treated neutrophils. Platelet-activating factor (PAF) (200 nmol·L−1) or N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) (1 µmol·L−1) were added as indicated (↑) when a stable baseline was obtained (±1 min). The traces shown are from three different representative experiments (8 for FMLP and 12 for PAF in the series).